The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Relationship between RECIST response and variation of circulating tumor cells (CTC) for patients enrolled in phase I trials.
Christophe Massard
Consultant or Advisory Role - Johnson & Johnson
Françoise Farace
No relevant relationships to disclose
Isabelle Borget
No relevant relationships to disclose
Christophe Le Tourneau
No relevant relationships to disclose
Jean-Yves Pierga
No relevant relationships to disclose
Francois Clement Bidard
No relevant relationships to disclose
Jean-Philippe Spano
No relevant relationships to disclose
Charles Ferte
No relevant relationships to disclose
Jean-Charles Soria
No relevant relationships to disclose
Ludovic Lacroix
No relevant relationships to disclose